Intervention Review

Targeted therapy for advanced renal cell carcinoma

  1. Chris Coppin1,*,
  2. Lyly Le2,
  3. Timothy J Wilt3,
  4. Christian Kollmannsberger1

Editorial Group: Cochrane Prostatic Diseases and Urologic Cancers Group

Published Online: 23 APR 2008

Assessed as up-to-date: 30 JUN 2010

DOI: 10.1002/14651858.CD006017.pub2


How to Cite

Coppin C, Le L, Wilt TJ, Kollmannsberger C. Targeted therapy for advanced renal cell carcinoma. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD006017. DOI: 10.1002/14651858.CD006017.pub2.

Author Information

  1. 1

    British Columbia Cancer Agency, Vancouver Centre, Vancouver, British Columbia, Canada

  2. 2

    British Columbia Cancer Agency, Fraser Valley Cancer Centre, Surrey, BC, Canada

  3. 3

    VAMC, General Internal Medicine (111-0), Minneapolis, Minnesota, USA

*Chris Coppin, British Columbia Cancer Agency, Vancouver Centre, 600 West 10th Avenue, Vancouver, British Columbia, V5Z 4E6, Canada. ccoppin@bccancer.bc.ca.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 23 APR 2008

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.